A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články
- MeSH
- chřipka lidská epidemiologie mortalita MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- senioři MeSH
- surveillance populace MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
Influenza related mortality rates have been established in many countries; nevertheless, studies focusing on the Central European population have been rare to date. We assess mortality attributable to influenza by comparing all cause mortality and mortality due to diseases of the circulatory system during influenza epidemic and non-epidemic periods, as defined by acute respiratory infection surveillance data. Data on total mortality, mortality due to diseases of the circulatory system and surveillance data for influenza and other respiratory infections were used in a general linear model with a logarithmic link for dependence of left censored mortality data over time, and week as a categorical factor. Results of the analysis show statistically significant (p <0.001) differences in excess mortality rates between influenza epidemic and non-epidemic periods in the Czech Republic between 1982 and 2000. We estimate that 2.17% of all cause mortality, and 2.57% of mortality due to diseases of the circulatory system throughout the study period was attributable to influenza, with an estimated annual average of 2661 and 1752 deaths respectively. The highest numbers of deaths were reported during seasons when influenza A/H3N2 was the predominant circulating strain. Improving vaccination coverage against influenza is considered to be the primary strategy for prevention of influenza associated mortality.
Zobrazit více v PubMed
Epidemiol Mikrobiol Imunol. 2003 Aug;52(3):105-16 PubMed
BMJ. 2002 Jan 12;324(7329):89-90 PubMed
MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40 PubMed
Vaccine. 2003 May 1;21(16):1780-5 PubMed
Acta Virol. 1958 Jan-Mar;2(1):52-61 PubMed
Int J Epidemiol. 1983 Sep;12(3):344-52 PubMed
Vaccine. 2003 May 1;21(16):1796-800 PubMed
BMJ. 2002 Jun 1;324(7349):1337; author reply 1337 PubMed
Commun Dis Public Health. 2000 Mar;3(1):32-8 PubMed
Vaccine. 2003 Mar 7;21(11-12):1137-48 PubMed
Am J Public Health. 1997 Dec;87(12):1944-50 PubMed
Public Health Rep. 1963 Jun;78(6):494-506 PubMed
Acta Virol. 1989 Jan;33(1):50-62 PubMed
Int J Epidemiol. 2001 Oct;30(5):1100-8 PubMed
Bull World Health Organ. 1973;49(3):219-33 PubMed
JAMA. 2003 Jan 8;289(2):179-86 PubMed
Vaccine. 2003 May 1;21(16):1769-75 PubMed
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
Impacts of hot and cold spells differ for acute and chronic ischaemic heart diseases
Excess cardiovascular mortality associated with cold spells in the Czech Republic
Decreased impacts of the 2003 heat waves on mortality in the Czech Republic: an improved response?